Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021.

Lamprini VenetiElina SeppäläMargrethe Larsdatter StormBeatriz Valcarcel SalamancaEirik Alnes BuanesNina AasandUmaer NaseerKaroline BragstadOlav HungnesHåkon BøåsReidar KvåleKaran GolestaniSiri FeruglioLine VoldKarin NygårdRobert Whittaker

Published in: PloS one (2021)

Our findings add to the growing evidence of a higher risk of severe disease among persons infected with B.1.1.7 or B.1.351. This highlights the importance of prevention and control measures to reduce transmission of these VOC in society, particularly ongoing vaccination programmes, and preparedness plans for hospital surge capacity.

Keyphrases

sars cov
public health
emergency department
respiratory syndrome coronavirus
copy number
healthcare
early onset
health insurance
adverse drug
gene expression
genome wide